Skip to main content
SpringerLink
Log in
Book cover

Tumor Suppressor Genes pp 315–347Cite as

The Tissue Microenvironment as an Epigenetic Tumor Modifier

  • Protocol

Part of the book series: Methods in Molecular Biology™ ((MIMB,volume 223))

Abstract

The transition from normal to cancerous tissue frequently takes years to occur. Epithelial tumors in particular can exist as premalignant lesions for prolonged periods of time, and even then only a low proportion of benign tumors undergo malignant transformation (1,2). Once tumors have formed, their behavior is often erratic, so that determining a treatment strategy based on current clinical criteria can be challenging. For example, some tumors may grow and invade aggressively, while tumors of similar grade can experience extended periods of dormancy (3–5). Tumor metastasis and drug responsiveness are also just as difficult to predict (6–8). This behavioral variability despite similarity in tumor phenotype demonstrates that cancer is a complex disease that is likely regulated by multiple pathways.

This is a preview of subscription content, log in via an institution.

Protocol
USD   49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. Hwang, E. and Eserman, L. (1999) Management of ductal carcinoma in situ. Surg. Clin. N. Am. 79(5), 1007–1030.

    PubMed  CAS  Google Scholar 

  2. Bergers, G. and Coussens, L. (2000) Extrinsic regulators of epithelial tumor progression: metalloproteinases. Curr. Opin. Genet. Dev. 10, 120–127.

    PubMed  CAS  Google Scholar 

  3. Demicheli, R., Retsky, M. W., Swartzendruber, D. E, and Bonadonna, G. (1997) Proposal for a new model of breast cancer metastatic development. Ann. Oncol. 8(11), 1075–1080.

    PubMed  CAS  Google Scholar 

  4. Riethmuller, G. and Klein, C. (2001) Early cancer cell dissemination and late metastatic relapse: clinical reflections and biological approaches tot he dormancy problem in patients. Semin. Cancer Biol. 11(4), 307–311.

    PubMed  CAS  Google Scholar 

  5. Tsao, H., Cosimi, A., and Sober, A. (1997) Ultra-late recurrence (15 years or longer) of cutaneous melanoma. Cancer 79(12), 2361–2370.

    PubMed  CAS  Google Scholar 

  6. Chambers, A., Naumov, G. N., Varghese, H. J., Nadkami, K. V., MacDonald, I. C., and Groom, A. C. (2001) Critical steps in hematogenous metastasis: an overview. Surg. Oncol. Clin. N. Am. 10(2), 243–255.

    PubMed  CAS  Google Scholar 

  7. Hart, I. (1999) Perspective: tumour spread—the problems of latency. J. Pathol. 187(1), 91–94.

    PubMed  CAS  Google Scholar 

  8. Kostler, W., Brodowicz, T., Hejna, M., Wiltschke, C., and Zielinski, C. C. (2000) Detection of minimal residual disease in patients with cancer: a review of techniques, clincal implications, and emerging therapeutic consequences. Cancer Detect. Prev. 24(4), 376–403.

    PubMed  CAS  Google Scholar 

  9. Kinzler, K. W. and Vogelstein, B. (1996) Lessons from hereditary colorectal cancer. Cell 87, 159–170.

    PubMed  CAS  Google Scholar 

  10. Hanahan, D. and Weinberg, R. (2000) The hallmark of cancer. Cell 100, 57–70.

    PubMed  CAS  Google Scholar 

  11. Compagni, A. and Christofori, G. (2000) Recent advances in research on multistage tumorigenesis. Br. J. Cancer 83(1), 1–5.

    PubMed  CAS  Google Scholar 

  12. Weinberg, E. (1989) Oncogenes, antioncogenes, and the molecular bases of multistep car-cinogenesis. Cancer Res. 49, 3713–3721.

    PubMed  CAS  Google Scholar 

  13. Farber, E. (1984) The multistep nature of cancer development. Cancer Res. 44, 4217–4223.

    PubMed  CAS  Google Scholar 

  14. Ponder, B. (2001) Cancer genetics. Nature 411(6835), 336–341.

    PubMed  CAS  Google Scholar 

  15. Macleod, K. (2000) Tumor suppressor genes. Curr. Opin. Genet. Dev. 10, 81–93.

    PubMed  CAS  Google Scholar 

  16. Fearnhead, N., Britton, M., and Bodmer, W. (2001) The ABC of APC. Hum. Mol. Genet. 10(7), 721–733.

    PubMed  CAS  Google Scholar 

  17. Kinzler, K. W. and Vogelstein, B. (1997) Cancer-susceptibility genes. Gatekeepers and caretakers [news; comment]. Nature 386(6627), 761–763.

    PubMed  CAS  Google Scholar 

  18. Kinzler, K. W. and Vogelstein, B. (1998) Landscaping the cancer terrain. Science 280, 1036–1037.

    PubMed  CAS  Google Scholar 

  19. Easton, D. F., Bishop, D. T., Ford, D., and Crockford, G. P. (1993) Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am. J. Hum. Genet. 52(4), 678–701.

    PubMed  CAS  Google Scholar 

  20. Struewing, J. P., Tarone, R. E., Brody, L. C., Li, F. P., and Boice, J. D., Jr. (1996) BRCA1 mutations in young women with breast cancer [letter]. Lancet 347(9013), 1493.

    PubMed  CAS  Google Scholar 

  21. Fodor, F. H., Weston, A., and Bleiweiss, I. J. (1998) Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients. Am. J. Hum. Genet. 63(1), 45–51.

    PubMed  CAS  Google Scholar 

  22. Maillet, P., Chappuis, P. O., Vaudan, G., et al. (2000) A polymorphism in the ATM gene modulates the penetrance of hereditary non-polyposis colorectal cancer. Int. J. Cancer 88(6), 928–931.

    PubMed  CAS  Google Scholar 

  23. Alonso, J., Garcia-Miguel, P., Abelairas, J., et al. (2001) Spectrum of germline RB1 gene mutations in Spanish retinoblastoma patients: phenotypic and molecular epidemological implications. Hum. Mutat. 17(5), 412–422.

    PubMed  CAS  Google Scholar 

  24. Ahmad, N., et al. (1999) A possible hot spot in exon 21 of the retinoblastoma gene predisposing to a low penetrant retinoblastoma phenotype? Ophthal. Genet. 20(4), 225–231.

    PubMed  CAS  Google Scholar 

  25. Baylin, S., Esteller, M., Rountree, M. R., Bachman, K..E, Schuebel, K., and Herman, J. G. (2001) Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum. Mol. Genet. 10(7), 687–692.

    PubMed  CAS  Google Scholar 

  26. Elenbaas, B., Spiro, L., Koerner, F., et al. (2001) Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev. 15(1), 50–65.

    PubMed  CAS  Google Scholar 

  27. Schor, S. and Schor, A. (2001) Phenotypic and genetic alterations in mammary stroma: implications for tumour progression. Breast Cancer Res. 3, 373–379.

    PubMed  CAS  Google Scholar 

  28. Radisky, D., Hagios, C. and Bissell, M. (2001) Tumors are unique organs defined by abnormal signaling and context. Semin. Cancer Biol. 11, 87–95.

    PubMed  CAS  Google Scholar 

  29. Bissell, M., Weaver, V. M. Lelievre, S. A., Wang, F., Peterson, O. W., and Schmeichel, K. L. (1999) Tissue structure, nuclear organization, and gene expression in normal and malignant breast. Cancer Res. 59(7 suppl.), 1757–1763.

    PubMed  CAS  Google Scholar 

  30. Barcellos-Hoff, M. (2001) It takes a tissue to make a tumor: epigenetics,cancer and the microenvironment. J. Mammary Gland Biol. Neoplasia 6(2), 213–221.

    PubMed  CAS  Google Scholar 

  31. Coussens, L. and Werb, Z. (2001) Inflammatory cells and cancer: think different! J. Exp. Med. 193(6), F23–F26.

    PubMed  CAS  Google Scholar 

  32. Liotta, L. and Kohn, E. (2001) The microenvironment of the tumour-host interface. Nature 411, 375–379.

    PubMed  CAS  Google Scholar 

  33. Park, C., Bissell, M. J., and Barcellos-Hoff, M. H. (2000) The influence of the microenvironment on the malignant phenotype. Mol. Med. Today 6, 324–329.

    PubMed  CAS  Google Scholar 

  34. Ronnov-Jessen, L., Peterson, O., and Bissell, M. (1996) Cellular changes involved in the conversion of normal to malignant breast: importance of the stromal reaction. Physiol. Rev. 76(1), 69–125.

    PubMed  CAS  Google Scholar 

  35. Sternlicht, M., Lochter, A., Sympson, C. J., et al. (1996) The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 98(2), 137–146.

    Google Scholar 

  36. Barcellos-Hoff, M. and Ravani, S. (2000) Irradiated mammary gland stroma promotes the expression of tumorigenesis potential by unirradiated epithelial cells. Cancer Res. 60(5), 1254–1260.

    PubMed  CAS  Google Scholar 

  37. Tlsty, T. and Hein, P. (2001) Know thy neighbor: stromal cells can contribute oncogenic signals. Curr. Opin. Genet. Dev. 11, 54–59.

    PubMed  CAS  Google Scholar 

  38. Tlsty, T. (2001) Stromal cells can contribute oncogenic signals. Cancer Biol. 11, 97–104.

    CAS  Google Scholar 

  39. Coussens, L., Tinkle, C. L., Hanahan, D., and Werb, Z. (2000) MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103(3), 481–490.

    PubMed  CAS  Google Scholar 

  40. Weaver, V., Petersen, O. W., Wang, F., et al. (1997) Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J. Cell Biol. 137, 231–245.

    PubMed  CAS  Google Scholar 

  41. Zutter, M., Santoro, S. A., Staatz, W. D., and Tsung, Y. L. (1995) Re-expression of the alpha 2 beta 1 integrin abrogates the malignant phenotype of breast carcinoma cells. Proc. Natl. Acad. Sci. USA 92(16), 7411–7415.

    PubMed  CAS  Google Scholar 

  42. Clegg, D., Mullick, L. H., Wingerd, K. L., et al. (2000) Adhesive events in retinal development and function: the role of integrin receptors. Results Probl. Cell Differ. 31, 141–156.

    PubMed  CAS  Google Scholar 

  43. Davies, J. and Davey, M. (1999) Collecting duct morphogenesis. Pediatr. Nephrol. 13(6), 535–541.

    PubMed  CAS  Google Scholar 

  44. Anderson, G., Harman, B. C., Hare, K. J., and Jenkinson, E. J. (2000) Microenvironmental regulation of T cell development in the thymus. Semin Immunol. 12(5), 457–464.

    PubMed  CAS  Google Scholar 

  45. Pires Neto, M., Braga-de-Souza, S., and Lent, R. (1999) Extracellular matrix molecules play diverse roles in the growth and guide central nervous system axons. Braz. J. Med. Biol. Res. 32(5), 633–638.

    Google Scholar 

  46. Zagris, N. (2001) Extracellular matrix in development of the early embryo. Micron 32(4), 427–438.

    PubMed  CAS  Google Scholar 

  47. De Arcangelis, A., and George-Labouesse, E. (2000) Integrin and ECM functions: roles in vertebrate development. Trends Genet. 16(9), 389–395.

    PubMed  Google Scholar 

  48. Tarone, G., Hirsch, E., and Brancaccio, M. (2000) Integrin function and regulation in development. Int. J. Dev. Biol. 44(6 spec. no.), 725–731.

    PubMed  CAS  Google Scholar 

  49. Sakakura, T., Nishizuka, Y., and Dawe, C. (1976) Mesenchyme-dependent morphogenesis and epithelium-specific cytodifferentiation in mouse mammary gland. Science 19, 1439–1441.

    Google Scholar 

  50. Hayward, S., Cunha, G., and Dahiya, R. (1996) Normal development and carcinogenesis of the prostate, a unifying hypothesis. Basis Cancer Management 784, 50–63.

    CAS  Google Scholar 

  51. Haigios, C., Lochter, A., and Bissell, M. J. (1998) Tissue architecture: the ultimate regulator of epithelial function? Phil. Trans. R. Soc. Lond., B: Biol. Sci. 353, 857–870.

    Google Scholar 

  52. Hoffman, M., Kibbey, M. C., Letterio, J. J., and Kleinman, H. K. (1996) Role of laminin-1 and TGF-beta 3 in acinar differentiation of a human submandibular gland cell line (HSG). J. Cell Sci. 109(8), 2013–2021.

    PubMed  CAS  Google Scholar 

  53. Boudreau, N. and Bissell, M. (1996) Regulation of gene expression by the extracellular matrix, in Extracellular Matrix; Molecular Components and Interactions (Comper, E., ed.). Harwood, Amsterdam, pp. 246–261.

    Google Scholar 

  54. Weaver, V., Fischer, A. H., Petersen, O. W., and Bissell, M. J. (1996) The importance of the microenvironment in breast cancer progression: recapitulation of mammary tumorigenesis using a unique human mammary epithelial cell model and a three-dimensional culture assay. Biochem. Cell Biol. 74, 833–851.

    PubMed  CAS  Google Scholar 

  55. Howe, A., Aplin, A. E., Alahari, S. K., and Juliano, R. L. (1998) Integrin signaling and cell growth control. Curr. Opin. Cell Biol. 10, 220–231.

    PubMed  CAS  Google Scholar 

  56. Martins-Green, M. and Bissell, M. (1995) (Cell-ECM interactions in development). Semin. Dev. Biol. 6, 149–159.

    CAS  Google Scholar 

  57. Schwarzbauer, J. and Sechler, J. (1999) Fibronectin fibrillogenesis: a paradigm for extracellular matrix assembly. Curr. Opin. Cell Biol. 11, 622–627.

    PubMed  CAS  Google Scholar 

  58. Hynes, R. and Hodivala-Dilke, K. (1999) Insights and questions arising from studies of a mouse model of Glanzmann thrombasthenia. Thromb. Haemost. 82(2), 481–485.

    PubMed  CAS  Google Scholar 

  59. Henry, M. and Campbell, K. (1999) Dystroglycan inside and out. Curr. Opin. Cell Biol. 11(5), 602–607.

    PubMed  CAS  Google Scholar 

  60. Rapraeger, A. (2000) Syndecan-regulated receptor signaling. J. Cell Biol. 149(5), 1143–1155.

    Google Scholar 

  61. Boudreau, N. and Bissell, M. (1998) Extracellular matrix signaling: integration of form and function in normal and malignant cells. Curr. Opin. Cell Biol. 10, 640–646.

    PubMed  CAS  Google Scholar 

  62. De Arcangelis, A. and Georges-Labouesse, E. (2000) Integrins and ECM functions: roles in vertebrate development. TIG 16(9), 389–395.

    PubMed  Google Scholar 

  63. Hynes, R. and Zhao, Q. (2000) The evolution of cell adhesion. J. Cell Biol. 150(2), F89–F95.

    PubMed  CAS  Google Scholar 

  64. Ashkenas, J., Damsky, C. H., Bissell, M. J., and Werb, Z. (1994) Integrins, signaling, and the remodeling of the extracellular matrix, in Integrins. Academic Press, New York, 79–109.

    Google Scholar 

  65. Brown, N. (2000) Cell-cell adhesion via the ECM: integrins genetics in fly and worm. Matrix Biol. 19(3), 191–201.

    PubMed  CAS  Google Scholar 

  66. Aszodi, A., Bateman, J. F., Gustafsson, E., Boot-Handford, R., and Fassler, R. (2000) Mammalian skeletogenesis and extracellular matrix: what can we learn from knockout mice? Cell Struct. Funct. 25(2), 73–84.

    PubMed  CAS  Google Scholar 

  67. Gustafsson, E. and Fassler, R. (2000) Insights into the extracellular matrix functions from the mutant mouse models. Exp. Cell Res. 261, 52–68.

    PubMed  CAS  Google Scholar 

  68. Critchley, D. (2000). Focal adhesions-the cytoskeletal connection. Curr. Opin. Cell Biol. 12(1), 133–139.

    PubMed  CAS  Google Scholar 

  69. Faull, R. and Ginsberg, M. (1996) Inside-out signaling through integrins. J. Am. Soc. Nephrol. 7(8), 1091–1097.

    PubMed  CAS  Google Scholar 

  70. Kumar, C. (1998) Signaling by integrin receptors. Oncogene 17(11), 1365–1373.

    PubMed  CAS  Google Scholar 

  71. Danen, E., Lafrenie, R. M., Miyamoto, S., and Yamada, K. M. (1998) Integrin signaling: cytoskeletal complexes, MAP kinase activation, and regulation of gene expression. Cell Adhes. Commun. 6(2–3), 217–224.

    PubMed  CAS  Google Scholar 

  72. LaFlamme, S. and Auer, K. (1996) Integrin signaling. Semin. Cancer Biol. 7, 111–118.

    PubMed  CAS  Google Scholar 

  73. Giancotti, F. and Ruoslahti, E. (1999) Integrin signaling. Science 285(5430), 1028–1032.

    PubMed  CAS  Google Scholar 

  74. Brown, E. and Frazier, W. (2001) Integrin-associated protein (CD47) and its ligands. Trends Cell Biol. 11(3), 130–135.

    PubMed  CAS  Google Scholar 

  75. Brown, D. and London, E. (1998) Functions of lipid rafts in biological membranes. Annu. Rev. Cell Dev. Biol. 14, 111–136.

    PubMed  CAS  Google Scholar 

  76. Maecker, H., Todd, S., and Levy, S. (1997) The tetraspanin superfamily: molecular facilitators. FASEB J. 11(6), 428–442.

    PubMed  CAS  Google Scholar 

  77. Burack, W. and Shaw, A. (2000) Signal transduction: hanging on a scaffold. Curr. Opin. Cell Biol. 12, 211–216.

    PubMed  CAS  Google Scholar 

  78. Ingber, D. (1998) In search of cellular control: signal transduction in context. J. Cell. Biochem. Suppl. 30–31, 232–237.

    PubMed  Google Scholar 

  79. Huang, S. and Ingber, D. (2000) Shape-dependent control of cell growth. differentiation, and apoptosis: switching between attractors in cell regulatory networks. Exp. Cell Res. 261(1), 91–103.

    PubMed  CAS  Google Scholar 

  80. Assoian, R. and Schwartz, M. (2001) Coordinate signaling by integrins and receptor tyrosine kinases in the regulation of G1 phase cell-cycle progression. Curr. Opin. Genet. Dev. 11(1), 48–53.

    PubMed  CAS  Google Scholar 

  81. Aplin, A., Howe, A., and Juliano, R. (1999) Cell adhesion molecules, signal transduction and cell growth. Curr. Opin. Cell Biol. 11, 737–744.

    PubMed  CAS  Google Scholar 

  82. Wang, F., Weaver, V. M., Petersen, O. W., et al. (1998) Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. Proc. Natl. Acad. Sci. USA 95(25), 14821–14826.

    PubMed  CAS  Google Scholar 

  83. Muschler, J., Lochter, A., Roskelley, C. D., Yurchenco, P., and Bissell, M. J. (1999) Division of labor among the alpha6beta4 integrin, beta1 integrins, and an E3 laminin receptor to signal morphogenesis and beta-casein expression in mammary epithelial cells. Mol. Biol. Cell 10(9), 2817–2828.

    PubMed  CAS  Google Scholar 

  84. Seljelid, R., Jozefowski, S., and Sveinbjornsson, B. (1999) Tumor stroma. Anticancer Res. 19(6A), 4809–4822.

    PubMed  CAS  Google Scholar 

  85. Lochter, A. and Bissell, M. (1995) Involvement of extracellular matrix constituents in breast cancer. Semin. Cancer Biol. 6(3), 165–173.

    PubMed  CAS  Google Scholar 

  86. Walker, R. (2001) The complexities of breast cancer desmoplasia. Breast Cancer Res. 3, 143–145.

    PubMed  CAS  Google Scholar 

  87. Ronnov-Jessen, L., Petersen, O. W., Koteliansky, V. E., and Bissell, M. J. (1995) The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. J. Clin. Invest. 95(2), 859–873.

    PubMed  CAS  Google Scholar 

  88. Dolberg, D., Hollingsworth, R., Hertle, M., and Bissell, M. J. (1985) Wounding and its role in RSV-mediated tumor formation. Science 230(4726), 676–678.

    PubMed  CAS  Google Scholar 

  89. Sieweke, M., Stoker, A., and Bissell, M. (1989) Evaluation of the cocarcinogenic effect of wounding in Rous sarcoma virus tumorigenesis. Cancer Res. 49(22), 6419–6424.

    PubMed  CAS  Google Scholar 

  90. Gailit, J. and Clark, R. (1994) Wound repair in the context of extracellular matrix. Curr. Opin. Cell Biol. 6(5), 717–725.

    PubMed  CAS  Google Scholar 

  91. Eckes, B., Zigrino, P., Kessler, D., et al. (2000) Fibroblast-matrix interactions in wound healing fibrosis. Matrix Biol. 19(4), 325–332.

    PubMed  CAS  Google Scholar 

  92. Sieweke, M. and Bissell, M. (1994) The tumor-promoting effect of wounding: a possible role for TGF-beta in stromal alterations. Crit. Rev. Oncogene. 5(2–3), 297–311.

    CAS  Google Scholar 

  93. Sieweke, M., Thompson, N. L., Sporn, M. B., and Bissell, M. J. (1990) Mediation of wound-related Rous sarcoma virus tumorigenesis by TGF-beta. Science 248(4963), 1656–1660.

    PubMed  CAS  Google Scholar 

  94. Martins-Green, M. and Bissell, M. (1990) Localization of 9E3/CEF-4 in avain tissues: expression is absent in Rous Sarcoma virus-induced tumors but is stimulated by injury. J. Cell Biol. 110(3), 581–595.

    PubMed  CAS  Google Scholar 

  95. Cunha, G. (1994) Role of mesenchymal-epithelial interactions in normal and abnormal development of the mammary gland and prostate. Cancer 74(3 suppl.), 1030–1044.

    PubMed  CAS  Google Scholar 

  96. Yang, J., Guzman, R., and Nandi, S. (2000) Histomorphologically intact primary human breast lesions and cancers can be propagated in nude mice. Cancer Lett. 159, 205–210.

    PubMed  CAS  Google Scholar 

  97. Schor, S. L. (1995) Fibroblast subpopulations as accelerators of tumor progression: the role of migration stimulating factor. EXS 74, 273–296.

    PubMed  CAS  Google Scholar 

  98. Olumi, A., Grossfeld, G. D., Hayward, S. W., Carroll, P. R., Tisty, T. D., and Cunha, G. R. (1999) Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 59(19), 5002–5011.

    PubMed  CAS  Google Scholar 

  99. Elenbaas, B. and Weinberg, R. (2001) Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp. Cell Res. 264(1), 169–184.

    PubMed  CAS  Google Scholar 

  100. Kleinman, H., Kablinski, J., Lee, S., and Engbring, J. (2001) Role of basement membrane in tumor growth and metastasis. Surg. Oncol. Clin. N. Am. 10(2), 329–338, ix.

    PubMed  CAS  Google Scholar 

  101. Bemis, L. and Schedin, P. (2000) Reproductive state of rat mammary gland stroma modulates human breast cancer cell migration and invasion. Cancer Res. 60(13), 3414–3418.

    PubMed  CAS  Google Scholar 

  102. Ruoslahti, E. (1999) Fibronectin and its integrin receptors in cancer. Adv. Cancer Res. 76, 1–20.

    PubMed  CAS  Google Scholar 

  103. Ivaska, J. and Heino, J. (2000) Adhesion receptors and cell invasion: mechanisms of integrin-guided degradation of extracellular matrix. Cell. Mol. Life 57(1), 16–24.

    CAS  Google Scholar 

  104. Weaver, V. and Bissell, M. (1999) Functional culture models to study mechanisms governing apoptosis in normal and malignant mammary epithelial cells. J. Mammary Gland Biol. Neoplasia 4(2), 193–201.

    PubMed  CAS  Google Scholar 

  105. Schmeichel, K., Weaver, V., and Bissell, M. (1998) Structural cues from the tissue microen-vironment are essential determinants of the human mammary epithelial cell phenotype. J. Mammary Gland Biol. Neoplasia 3(2), 201–213.

    PubMed  CAS  Google Scholar 

  106. Robbins, S. L., Angell, M., and Kumar V. (1981) Basic Pathology, 3rd ed. Saunders, Philadelphia.

    Google Scholar 

  107. Gumbiner, B. (1996) Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84(3), 345–357.

    PubMed  CAS  Google Scholar 

  108. Hagios, C., Lochter, A., and Bissell, M. (1998) Tissue architecture: the ultimate regulator of epithelial function? Phil. Trans. R. Soc. Lond. 353, 857–870.

    CAS  Google Scholar 

  109. Yeaman, C., Grindstaff, K., and Nelson, W. (1999) New perspectives on mechanisms involved in generating epithelial cell polarization. Physiol. Rev. 79(1), 73–98.

    PubMed  CAS  Google Scholar 

  110. Lelievre, S., Weaver, V. M., Nickerson, J. A., et al. (1998) Tissue phenotype depends on reciprocal interactions between the extracellular matrix and the structural organization of the nucleus. Proc. Natl. Acad. Sci. USA 95(25), 14711–14716.

    PubMed  CAS  Google Scholar 

  111. Lohi, J., Leivo, I., Oivula, J., Lehto, V. P., and Virtanen, I. (1998) Extracellular matrix in renal cell carcinomas. Histol. Histopathol. 13(3), 785–796.

    PubMed  CAS  Google Scholar 

  112. Jones, P. (2001) Extracellular matrix and tenascin-C in pathogenesis of breast cancer. Lancet 357(9273), 1992–1994.

    PubMed  CAS  Google Scholar 

  113. De Iorio, P., Midulla, C., Pisani, T., et al. (2001) Implication of laminin and collagen type IV expression in the progression of breast carcinoma. Anticancer Res. 21(2B), 1395–1399.

    PubMed  Google Scholar 

  114. Zvibel, I., et al.(2000) The role of the liver environment in the regulation of colon cancer metastasis. Isr. Med. Assoc. J. 2(1), 48–51.

    PubMed  CAS  Google Scholar 

  115. Ellenrieder, V., Adler, G., and Gress, T. (1999) Invasion and metastatsis in pancreatic cancer. Ann. Oncol. 10(suppl.), 46–50.

    PubMed  Google Scholar 

  116. Rowley, D. (1998–1999) What might a stromal response mean to prostate cancer progression? Cancer Metastasis Rev. 17(4), 411–419.

    PubMed  CAS  Google Scholar 

  117. Catusse, C., Polette, M., Coraux, C., Burlet, H., and Birembaut, P. (2000) Modified basement membrane composition during bronchopulmonary tumor progression. J. Histochem. Cytochem. 48(5), 663–669.

    PubMed  CAS  Google Scholar 

  118. Korhonen, M., Latinen, L., Yianne, J., Gould, V. E., and Virtanen, I. (1992) Integrins in developing, normal and malignant human kidney. Kidney Int. 41(3), 641–644.

    PubMed  CAS  Google Scholar 

  119. Zutter, M., Sun, H., and Santoro, S. (1998) Altered integrin expression and the malignant phenotype: the contribution of multiple integrin receptors. J. Mammary Gland Biol. Neoplasia 3(2), 191–200.

    PubMed  CAS  Google Scholar 

  120. Shaw, L. (1999) Integrin function in breast carcinoma progression. J. Mammary Gland Biol. Neoplasia 4(4), 367–376.

    PubMed  CAS  Google Scholar 

  121. Agrez, M. and Bates, R. (1994) Colorectal cancer and the integrin family of cell adhesion receptors: current status and future. Eur. J. Cancer 30A(14), 2166–2170.

    PubMed  CAS  Google Scholar 

  122. Kemperman, H., Driessens, M. H., La Riviere, G., Meijne, A. M., and Roos, E. (1995) Adhesion mechanisms in liver metastasis formation. Cancer Surv. 24, 67–79.

    PubMed  CAS  Google Scholar 

  123. Weinacker, A., Ferrando, R., Elliott, M., Hogg, J., Balmes, J., and Sheppard, D. (1995) Distribution of integrins alpha v beta 6 and alpha 9 beta 1 and their known ligands, fibronectin, tenascin, in human airways. Am. J. Respir. Cell Mol. Biol. 12(5), 547–556.

    PubMed  CAS  Google Scholar 

  124. Petersen, O. W., Ronnov-Jessen, L., Howlett, A. R., and Bissell, M. J. (1992) Interaction with basement membrane serves to rapidly distinguish grwoth and differentiation pattern of normal and malignant human breast epithelial cells. Proc. Natl. Acad. Sci. USA 89, 9064–9068.

    PubMed  CAS  Google Scholar 

  125. Howlett, A., Petersen, O. W., Steeg, P. S., and Bissell, M. J. (1994) A novel function for the nm23-H1 gene: Overexpression in human breast carcinoma cells leads to the formation of basement membrane and growth arrest. J. Natl. Cancer Inst. 86(24).

    Google Scholar 

  126. Briand, P., Peterson, O., and Van Deurs, B. (1987) A new diploid nontumorigenic human breast epithelial cell line isolated and propagated in chemically defined medium. In Vitro Cell Dev Biol. 123(3), 181–188.

    Google Scholar 

  127. Briand, P., Nielsen, K. V., Madsen, M. W., and Petersen, O. W. (1996) Trisomy 7p and malignant transformation of human breast epithelial cells following epidermal growth factor withdrawal. Cancer Res. 56(9), 2039–2044.

    PubMed  CAS  Google Scholar 

  128. Nielsen, K., Niebuhr, E., Ejlertsen, B., et al. (1997) Molecular cytogenetic analysis of a nontumorigenic human breast epithelial cell line that eventually turns tumorigenic: validation of an analytical approach combining karyotyping, comparative genomic hybridization, chromosome painting, and single-locus fluorescence in sity hybridization. Genes Chromosomes Cancer 20(1), 30–37.

    PubMed  CAS  Google Scholar 

  129. Villadsen, R., Nielsen, K. V., Bolund, L., and Briand, P. (2000) Complete loss of wild-type TP53 in a nontransformed human epithelial cell line preceded by a phase during which a heterozygous TP53 mutant effectively outgrows the homozygous wild-type cells. Cancer Genet. Cytogenet. 116(1), 28–34.

    PubMed  CAS  Google Scholar 

  130. Madsen, M., Lykkesfeldt, A. E., Laursen, I., Nielsen, K. V., and Briand, P. (1992) Altered gene expression of c-myc, epidermal growth factor receptor, transforming growth factor-alpha, and c-erb-B2 in an immortalized human breast epithelial cell line, HMT-3522, is associated with decreased growth requirements. Cancer Res. 52(5), 1210–1217.

    PubMed  CAS  Google Scholar 

  131. Javaherian, A., Vaccariello, M., Fusenig, N. E., and Garlick, J. A. (1998) Normal keratinocytes suppress early stages of neoplastic progression in stratified epithelium. Cancer Res. 58, 2200–2208.

    PubMed  CAS  Google Scholar 

  132. Karen, J., Wang, Y., Javaherian, A., Vaccariello, M., Fusenig, N. E., and Garlick, J. A. (1999) 12-O-Tetradecanoylphorbol-13-acetate induces clonal expansion of potentially malignant keratinocytes in a tissue model of early neoplastic progression. Cancer Res. 59, 474–481.

    PubMed  CAS  Google Scholar 

  133. Schwartz, M. (1997) Integrins, oncogenes, and anchorage independence. J. Cell Biol. 139(3), 575–578.

    PubMed  CAS  Google Scholar 

  134. Frisch, S. and Ruoslahti, E. (1997) Integrins and anoikis. Curr. Opin. Cell Biol. 9, 701–706.

    PubMed  CAS  Google Scholar 

  135. O’Connor, P. (1997) Mammalian G1 and G2 checkpoints. Cancer Surv. 29, 151–182.

    Google Scholar 

  136. Day, M., Foster, R. G., Day, K. C., et al. (1997) Cell anchorage regulated apoptosis through the retinoblastoma tumor suppressor/E2F pathway. J. Biol. Chem. 272(13), 8125–8128.

    PubMed  CAS  Google Scholar 

  137. Tsuboi, N., Yoshida, H., Kawamura, T., Furukawa, Y., Hosoya, T., and Yamada, H. (2000) Three-dimensional matrix suppresses E2F-controlled gene expression in glomerular mesangial cells. Kidney Int. 57, 1581–1589.

    PubMed  CAS  Google Scholar 

  138. Yu, Q., Geng, Y., and Sicinski, P. (2001) Specific protection against breast cancers by cyclin D1 ablation. Nature 411, 1017–1021.

    PubMed  CAS  Google Scholar 

  139. Ghosh, A., Yuan, W., Mori, Y., Chen, S., and Varga, J. (2001) Antagonistic regulation of type 1 collagen gene expression by interferon-gamma and transforming growth factor-beta. J. Biol. Chem. 276(14), 11041–11048.

    PubMed  CAS  Google Scholar 

  140. Pasche, B. (2001) Role of transforming growth factor beta in cancer. J. Cell. Physiol. 186, 153–168.

    PubMed  CAS  Google Scholar 

  141. Hata, A. (2001) TGF-beta signaling and cancer. Exp. Cell Res. 264, 111–116.

    PubMed  CAS  Google Scholar 

  142. Zhou, S., Buckhaults, P., Zawel, L., et al. (1998) Targeted deletion of SMAD4 shoes it is required for transforming growth factor beta and activin signaling in colorectal cancer cells. Proc. Natl. Acad. Sci. USA 95, 2412–2416.

    PubMed  CAS  Google Scholar 

  143. Riggins, G., Kinzler, K. W., Vogelstein, B., and Thiagalingam, S. (1997) Frequency of Smad gene mutations in human cancers. Cancer Res. 57(13), 2578–2580.

    PubMed  CAS  Google Scholar 

  144. Dalton, S., Scharf, E., Davey, G., and Assoian, R. K. (1999) Transforming growth factorbeta overrides the adhesion requirement for surface expression of alpha(5)beta(1) integrin in normal rat kidney fibroblasts. A necessary effect for induction of anchorage independent growth. J. Biol. Chem. 274(42), 30139–30145.

    PubMed  CAS  Google Scholar 

  145. Lai, C., Feng, X., Nishimura, R., et al. (2000) Transforming growth factor-beta up-regulates the beta5 integrin subunit expression via sp1 and smad signaling. J. Biol. Chem. 275(46), 36400–36406.

    PubMed  CAS  Google Scholar 

  146. Weitzman, J. (2000) Quick guide. Jnk. Curr. Biol. 10(8), R290.

    PubMed  CAS  Google Scholar 

  147. Almeida, E., Ilic, D., Han, Q., et al. (2000) Matrix survival signaling: from fibronectin via focal adhesion kinase to c-Jun NH(2)-terminal kinase. J. Cell Biol. 149(3), 741–754.

    PubMed  CAS  Google Scholar 

  148. Scatena, M., Almeida, M., Chaisson, M. L., Fausto, N., Nicosia, R. F., and Giachelli, C. M. (1998) NF-kappaB mediates alpha five beta three integrin-induced endothelial cell survival. J. Cell Biol. 141(4), 1083–1093.

    PubMed  CAS  Google Scholar 

  149. Frisch, S., Vuori, K., Kelaita, D., and Sicks, S. (1996) A role for Jun-N-terminal kinase in anoikis; suppression by bcl-2 and crmA. J. Cell Biol. 135(5), 1377–1382.

    PubMed  CAS  Google Scholar 

  150. Mc Donald, E. R. and El-Deiry, W. (2001) Checkpoint genes in cancer. Ann. Med. 33(2), 113–122.

    CAS  Google Scholar 

  151. Ryan, K., Phillips, A., and Vousden, K. (2001) Regulation and function of the p53 tumor suppressor protein. Curr. Opin. Cell Biol. 13, 332–337.

    PubMed  CAS  Google Scholar 

  152. Nigro, J., Aldape, K. D., Hess, S. M., and Tisty, T. D. (1997) Cellular adhesion regulates p53 protein levels in primary human keratinocytes. Cancer Res. 57, 3635–3639.

    PubMed  CAS  Google Scholar 

  153. Tlsty, T. (1998) Cell-adhesion-dependent influences on genomic instability and carcinogenesis. Curr. Opin. Biol. 10(5), 647–653.

    CAS  Google Scholar 

  154. O’Connell, F. and Martin, F. (2000) Laminin-rich extracellular matrix association with mammary epithelial cells suppresses Brca1 expression. Cell Death Different. 7(4), 360–367.

    Google Scholar 

  155. Marquis, S. T., Rajan, J. V., Wynshaw-Boris, A., et al. (1995) The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues. Nature Genet. 11(1), 17–26.

    PubMed  CAS  Google Scholar 

  156. Rajan, J. V., Wang, M., Marquis, S. T., and Chodash, L. A. (1996) Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells. Proc. Natl. Acad. Sci. USA 93(23), 13078–13083.

    PubMed  CAS  Google Scholar 

  157. Wang, A., Schneider-Broussard, R., Kumar, A. P., MacLeod, M. C., and Johnson, D. G. (2000) Regulation of BRCA1 expression by the Rb-E2F pathway. J. Biol. Chem. 275, 4532–4536.

    PubMed  CAS  Google Scholar 

  158. Satterwhite, D., Matsunami, N., and White, R. (2000) TGF-beta1 inhibits BRCA1 expression through a pathway that requires pRb. Biochem. Biophysic. Res. Commun. 276, 686–692.

    CAS  Google Scholar 

  159. Chrenek, M., Wong, P., and Weaver, V. (2001) Integrins and cell adhesions as modulators of mammary cell survival and transformation. Breast Cancer Res. 3(4), 224–229.

    PubMed  CAS  Google Scholar 

  160. Boudreau, N., Werb, Z., and Bissell, M. (1996) Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawl from the cell cycle. Proc. Natl. Acad. Sci. USA 93(8), 3509–3913.

    PubMed  CAS  Google Scholar 

  161. Welcsh, P. L., Owens, K. N., and King, M. C. (2000) Insights into the functions of BRCA1 and BRCA2. Trends Genet. 16(2), 69–74.

    PubMed  CAS  Google Scholar 

  162. Okamoto, A., Demetrick, D. J., Spillare, E. A., et al. (1994) Mutations and altered expression of p16INK4 in human cancer. Proc. Natl. Acad. Sci. USA 91, 11045–11049.

    PubMed  CAS  Google Scholar 

  163. Serrano, M. (1997) The tumor suppressor protein p16INK4A. Exp. Cell Res. 237, 7–13.

    PubMed  CAS  Google Scholar 

  164. Stolle, C., Glenn, G., Zbar, B., et al. (1998) Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum. Mutat. 12(6), 417–423.

    PubMed  CAS  Google Scholar 

  165. Kondo, K. and Kaelin, W. (2001) The von Hippel-Lindau tumor suppressor gene. Exp. Cell Res. 264 (117–125).

    PubMed  CAS  Google Scholar 

  166. Kamada, M., Suzuki, K., Kato, Y., Okuda, H., and Shuin, T. (2001) von Hippel-Lindau protein promotes the assembly of actin and vinculin and inhibits cell motility. Cancer Res. 61, 4184–4189.

    PubMed  CAS  Google Scholar 

  167. Plath, T., Detjen, K., Welzel, M., et al. (2000) A novel function for the tumor suppressor p16INK4a: Induction of anoikis via upregulation of the alpha-five beta-one Fibronectin Receptor. J. Cell Biol. 150(6), 1467–1477.

    PubMed  CAS  Google Scholar 

  168. Fahraeus, R. and Lane, D. (1999) The p16INK4a tumour suppressor protein inhibits alpha-v beta-3 integrin-mediated cell spreading on vitronectin by blocking PKC-dependent localization of alpha-v beta-3 to focal contacts. EMBO J. 18(8), 2106–2118.

    PubMed  CAS  Google Scholar 

  169. Romanov, S., Kozakiewicz, B. K., Holst, C. R., Stampfer, M. R., Haupt, L. M., and Tisty, T. D. (2001) Normal human mammary epithelial cells spontaneously escape senescence acquire genomic changes. Nature 409(6820), 633–637.

    PubMed  CAS  Google Scholar 

  170. Spancake, K. M., Anderson, C. B., Weaver, V. M., Matsunami, M., Bissell, M. J. and White, R. L. (1999) E7-transduced human breast epithelial cells show partial differentiation in three-dimensional culture. Cancer Res. 59, 6042–6045.

    PubMed  CAS  Google Scholar 

  171. Lim, S., Lee, H., and Lee, H. (1998) Inhibition of colonization and cell-matrix adhesion after nm23-H1 transfection of human prostate carcinoma cells. Cancer Lett. 133(2), 143–149.

    PubMed  CAS  Google Scholar 

  172. Kreidberg, J. (2000) Functions of alpha3beta1 integrin. Curr. Opin. Cell Biol. 12(5), 548–553.

    PubMed  CAS  Google Scholar 

  173. Hofmann, U., Westphal, J. R., Van Muijen, G. N., and Ruiter, D. J. (2000) Matrix metallo-proteinases in human melanoma. J. Invest. Dermatol. 115(3), 337–344.

    PubMed  CAS  Google Scholar 

  174. Zhang, X., Bontrager, A., and Hemler, M. (2001) Transmembrane-4 Superfamily Proteins Associate with Activated Protein Kinase C (PKC) and Link PKC to Specific beta1 Integrins. J. Biol. Chem. 276(27), 25005–25013.

    PubMed  CAS  Google Scholar 

  175. Odintsova, E., Sgiura, T., Berditchevski, F. (2000) Attenuation of EGF receptor signaling by a metastasis suppressor, the tetraspanin CD82/KAI-1. Curr. Biol. 10(16), 1009–1012.

    PubMed  CAS  Google Scholar 

  176. Ruoslahti, E. (1994) Cell adhesion and tumor metastasis. Princess Takamatsu Symp. 24, 99–105.

    PubMed  CAS  Google Scholar 

  177. Huang, S. and Ingber, D. (1999) The structural and mechanical complexity of cell-growth control. Nat. Cell Biol. 1, E131–E138.

    PubMed  CAS  Google Scholar 

  178. Myers, C., Schmidhauser, C., Mellentin-Michelotti, J., et al. (1998) Characterization of BCE-1, a transcriptional enhancer regulated by prolactin and extracellular matrix and modulated by the state of histone acetylation. Mol. Cell. Biol. 18(4), 2184–2195.

    PubMed  CAS  Google Scholar 

  179. Somasiri, A., Howarth, A., Goswami, D., Dedhar, S., and Roskelley, C. D. (2001) Overex-pression of the integrin-linked kinase mesenchymally transforms mammary epithelial cells. J. Cell Sci. 114(pt. 6), 1125–1136.

    PubMed  CAS  Google Scholar 

  180. Lampe, P., Nguyen, B. P., Gil, S., et al. (1998) Cellular interaction of integrin alpha3beta1 with laminin 5 promotes gap junctional communication. J. Cell. Biol. 143(6), 1735–1747.

    PubMed  CAS  Google Scholar 

  181. von Schlippe, M., Marshall, J. F., Perrry, P., Stone, M., Zhu, A. J., and Hart, I. R. (2000) Functional interaction between E-cadherin and alphav-containing integrin carcinoma cells. J. Cell Sci. 113(pt. 3), 425–437.

    Google Scholar 

  182. Guilford, P., Hopkins, J. B., Grady, W. M., et al. (1998) E-cadherin germline mutations in familial gastric cancer. Nature 392, 402–405.

    PubMed  CAS  Google Scholar 

  183. Kemler, R. (1993) From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet. 9(9), 317–321.

    PubMed  CAS  Google Scholar 

  184. Peifer, M. (1993) The product of Drosophila segment polarity gene armadillo is part of a multi-protein complex resembling the vertebrate adherens junction. J. Cell Sci. 105(pt. 4), 993–1000.

    PubMed  CAS  Google Scholar 

  185. Wodarz, A. and Nusse, R. (1998) Mechanisms of Wnt signaling in development. Ann. Rev. Cell Dev. Biol. 14, 59–88.

    CAS  Google Scholar 

  186. He, T., Sparks, A. B., et al. (1998) Identification of cMyc as a target of the APC pathway. Science 281, 1509–1512.

    PubMed  CAS  Google Scholar 

  187. Tetsu, O. and McCormick, F. (1999) Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398, 422–426.

    PubMed  CAS  Google Scholar 

  188. Novak, A., Hsu, S. C., Leung-Hagesteijn, C., et al. (1998) Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways. Proc. Natl. Acad. Sci. USA 95(8), 4374–4379.

    PubMed  CAS  Google Scholar 

  189. Daniel, J. and Reynolds, A. (1999) The catenin p120(ctn) interacts with Kaiso, a novel BTB/POZ domain zinc-finger transcription factor. Mol. Cell Biol. 19(5), 3614–3623.

    PubMed  CAS  Google Scholar 

  190. Balda, M. and Matter, K. (2000) The tight junction protein ZO-1 and an interacting transcription factor regulate ErbB-2 expression. EMBO J. 19(9), 2024–2033.

    PubMed  CAS  Google Scholar 

  191. Caldas, C. and Aparicio, S. (1999) Cell memory and cancer-the story of trithorax and Poly-comb group genes. Cancer Metastasis Rev. 18, 313–329.

    PubMed  CAS  Google Scholar 

  192. Nakamura, T., Blechman, J., Tada, S., et al. (2000) huASH1 protein, a putative transcription factor encoded by a human homologue of the Drosophila ash 1 gene, localizes to both nuclei and cell-cell tight junctions. Proc. Natl. Acad. Sci. USA 97(13), 7284–7289.

    PubMed  CAS  Google Scholar 

  193. Brock, H. and van Lohuizen, M. (2001) The Polycomb group-no longer an exclusive club? Curr. Opin. Genet. Dev. 11, 175–181.

    PubMed  CAS  Google Scholar 

  194. Chen, H., Schmeichel, K. L., Mian, I. S., Lelievre, S., Petersen, O. W., and Bissell, M. J. (2000) AZU-1: a candidate breast tumor suppressor and biomarker for tumor progression. Mol. Biol. Cell 11(4), 1357–1367.

    PubMed  CAS  Google Scholar 

  195. Huang, R., Fan, Y., Hossain, M. Z., Peng, A., Zeng, Z. L., and Boynton, A. L. (1998) Reversion of the neoplastic phenotype of human glioblastoma cells by connexin 43 (cx43). Cancer Res. 58, 5089–5096.

    PubMed  CAS  Google Scholar 

  196. Doyle, J., Stempak, J. G., Cowin, P., Colman, D. R., and D’Urso, D. (1995) Protein zero, a nervous system adhesion molecule, triggers epithelial reversion in host carcinoma cells. J. Cell Biol. 131(2), 465–482.

    PubMed  CAS  Google Scholar 

  197. Aberle, H., Bauer, A., Stappert, J., Kispert, A., and Kemler, R. (1997) Beta-catenin is a target for the ubiquitin-proteosome pathway. EMBO J. 1997. 16(13), 3797–3804.

    PubMed  CAS  Google Scholar 

  198. Orford, K., Crokett, C., Jensen, J. P., Weissman, A. M., and Byers, S. W. (1997) Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin. J. Biol. Chem. 272(40), 24735–24738.

    PubMed  CAS  Google Scholar 

  199. Salomon, D., Sacco, P. A., Roy, S. G., et al. (1997) Regulation of beta-catenin levels and localization by overexpression of plakoglobin and inhibition of the ubiquitin-proteosome system. J. Cell Biol. 139(5), 1325–1335.

    PubMed  CAS  Google Scholar 

  200. Munemitsu, S., Albert, I., Souza, B., Rubinfeld, B., and Polakis, P. (1995) Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc. Natl. Acad. Sci. USA 192, 3046–3050.

    Google Scholar 

  201. Morin, P., Sparks, A. B., Korinek, V., et al. (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutation in beta-catenin or APC. Science 275, 1787–1790.

    PubMed  CAS  Google Scholar 

  202. Barth, A., Nathke, I., and Nelson, W. (1997) Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways. Curr. Opin. Cell Biol. 9(5), 683–690.

    PubMed  CAS  Google Scholar 

  203. Day, M., Zhao, X., Vallorosi, C. J., et al. (1999) E-cadherin mediates aggregation-dependent survival of prostate and mammary epithelial cells through the retinoblastoma cell cycle control pathway. J. Biol. Chem. 274(14), 9656–9664.

    PubMed  CAS  Google Scholar 

  204. Persad, S., Troussard, A. A., McPhee, T. R., Mulholland, D. J., and Dedhar, S. (2001) Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation. J. Cell Biol. 153(6), 1161–1173.

    PubMed  CAS  Google Scholar 

  205. Liu, J., Stevens, J., Rote, C. A., et al. (2001) Siah-1 mediates a novel beta-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein. Mol. Cell 7, 927–936.

    PubMed  CAS  Google Scholar 

  206. Wolfee, A. and Matzke, M. (1999) Epigenetics: regulation through repression. Science 286, 5439.

    Google Scholar 

  207. Cheung, W., Briggs, S., and Allis, C. (2000) Acetylation and chromosomal functions. Curr. Opin. Cell Biol. 12(3), 326–333.

    PubMed  CAS  Google Scholar 

  208. Sun, Y., Kolligs, F. T., Hottiger, M. O., Mosavin, R., Fearon, E. R., and Nabel, G. J. (2000) Regulation of beta-catenin transformation by the p300 transcriptional coactivator. Proc. Natl. Acad. Sci. USA 97(23), 12613–12618.

    PubMed  CAS  Google Scholar 

  209. Marmorstein, R. (2001) Structure and function of histone acetyltransferases. Cell. Mol. Life Sci. 58(5–6), 693–703.

    PubMed  CAS  Google Scholar 

  210. Lee, J., Lee, Y. C., Na, S. Y., Jung, D. J., and Lee, S. K. (2001) Transcriptional coregulators of the nuclear receptor superfamily: coactivators and corepressors. Cell. Mol. Life Sci. 58(2), 289–297.

    PubMed  CAS  Google Scholar 

  211. Pao, G., Janknecht, R., Ruffner, H., Hunter, T., and Verma, I. M. (2000) CBP/p300 interact with and function as transcriptional coactivators of BRCA1. Proc. Natl Acad. Sci. USA 97(3), 1020–1025.

    PubMed  CAS  Google Scholar 

  212. Miyagishi, M., Fujii, R., Hatta, M., et al. (2000) Regulation of Lef-mediated transcription and p53-dependent pathway by associating beta-catenin with CBP/p300. J. Biol.Chem. 275(45), 35170–35175.

    PubMed  CAS  Google Scholar 

  213. Ali, S. and DeCaprio, J. (2001) Cellular transformation by SV40 large T antigen: interaction with host proteins. Semin. Cancer Biol. 11(1), 15–23.

    PubMed  CAS  Google Scholar 

  214. Goodman, R. and Smolik, S. (2000) CBP/p300 in cell growth/transformation, and development. Genes Dev. 14(13), 1553–1577.

    PubMed  CAS  Google Scholar 

  215. de Caestecker, M., Yahata, T., Wang, D., et al. (2000) The Smad4 activation domain (SAD) is a proline-rich, p300-dependent transcriptional activation domain. J. Biol. Chem. 275(3), 2115–2122.

    PubMed  Google Scholar 

  216. Eid, J., Kung, A. L., Scully, R., and Livingston, D. M. (2000) p300 interacts with the nuclear proto-oncoprotein SYT as part of the active control of cell adhesion. Cell 102(6), 839–848.

    PubMed  CAS  Google Scholar 

  217. Miller, K., Chung, J., Lo, D., Jones, J. C., Thimmapaya, B., and Weitzman, S. A. (2000) Inhibition of laminin-5 production in breast epithelial cells by overexpression of p300. J. Biol. Chem. 275(11), 8176–8182.

    PubMed  CAS  Google Scholar 

  218. Grooteclaes, M. and Frisch, S. (2000) Evidence for a function of CtBP in epithelial gene regulation and anoikis. Oncogene 19(33), 3823–3828.

    PubMed  CAS  Google Scholar 

  219. Cillo, C., Cantile, M., Faiella, A., and Boncinelli, E. (1999) Homeobox genes and cancer. Exp. Cell Res. 248(1), 1–9.

    PubMed  CAS  Google Scholar 

  220. Boudreau, N., Andrews, C., Srebronx, A., Ravanpay, A., and Cheresh, D. A. (1997) Hox D3 induces an angiogenic phenotype. J. Cell Biol. 139, 257–264.

    PubMed  CAS  Google Scholar 

  221. Myers, C., Charboneau, A., and Boudreau, N. (2000) Homeobox B3 promotes capillary morphogenesis and angiogenesis. J. Cell Biol. 148(2), 343–351.

    PubMed  CAS  Google Scholar 

  222. Srebrow, A., Friedman, Y., Ravanpay, A., Daniel, C. W., and Bissell, M. J. (1998) Expression of HOXA-1 and HOXB-7 is regulated by ECM dependent signals in mammary epithelial cells. J. Cell Biochem. 69(4), 377–391.

    PubMed  CAS  Google Scholar 

  223. Chariot, A. and Castronova, V. (1996) Detection of HOXA1 expression in human breast cancer. Biochem. Biophys. Res. Commun. 222(2), 292–297.

    PubMed  CAS  Google Scholar 

  224. Soubeyran, P., Haglund, K., Garcia, S., Barth, B. U., Iovanna, J., and Dikic, I. (2001) Homeobox gene Cdx1 regulates Ras, Rho, and PI3 kinase pathways leading to transformation and tumorigenesis of intestinal epithelial cells. Oncogene 20(31) 4180–4187.

    PubMed  CAS  Google Scholar 

  225. Soubeyran, P., Mallo, G. V., Moucadel, V., Dagom, J. C., and Iovanna, J. L. (2000) Over-expression of Cdx1 and Cdx2 homeogenes enhances expression of HLA-I in HT-29 cells. Mol. Cell. Biol. Res. Commun. 3(5), 271–276.

    PubMed  CAS  Google Scholar 

  226. Lorentz, O., Duluc, I., Arcangelis, A. D., Simon-Assmann, P., Kedinger, M., and Freund, J. M. (1997) Key role of the Cdx2 homeobox gene in extracellular matrix-mediated in cell differentiation. J. Cell Biol. 139(6), 1553–1565.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abramson Family Cancer Research Institute, University of Pennsylvania Cancer Center, Philadelphia, PA

    Meredith Unger

  2. Department of Pathology, The Institute for Medicine and Engineering, University of Pennsylvania, Philadelphia, PA

    Valerie M. Weaver

Authors
  1. Meredith Unger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Valerie M. Weaver
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA

    Wafik S. El-Deiry MD, PhD

  2. Department of Genetics, University of Pennsylvania School of Medicine, Philadelphia, PA

    Wafik S. El-Deiry MD, PhD

  3. Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, PA

    Wafik S. El-Deiry MD, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Humana Press Inc.

About this protocol

Cite this protocol

Unger, M., Weaver, V.M. (2003). The Tissue Microenvironment as an Epigenetic Tumor Modifier. In: El-Deiry, W.S. (eds) Tumor Suppressor Genes. Methods in Molecular Biology™, vol 223. Humana Press. https://doi.org/10.1385/1-59259-329-1:315

Download citation

  • DOI: https://doi.org/10.1385/1-59259-329-1:315

  • Publisher Name: Humana Press

  • Print ISBN: 978-0-89603-987-2

  • Online ISBN: 978-1-59259-329-3

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation